Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Liu · SciRah

Researcher profile · Semantic Scholar

G. Liu

Share profile

G. Liu — researcher profile on SciRah

h-index: 7
Works: 18
Citations: 177

Most-cited papers

Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trial.
A. Zurita, D. George, N. Shore, G. Liu +9 more
2012Annals of Oncology51 citations Open access
Semantic Scholar
Phase I/II trial of CCI 779 and bevacizumab in advanced renal cell carcinoma (RCC): Safety and activity in RTKI refractory RCC patients.
J. Merchan, H. Pitot, R. Qin, G. Liu +4 more
2009Journal of Clinical Oncology36 citations
Semantic Scholar
Axitinib second-line therapy for metastatic renal cell carcinoma (mRCC): Five-year (yr) overall survival (OS) data from a phase II trial.
R. Motzer, T. de la Motte Rouge, A. Harzstark, M. Michaelson +7 more
2011Journal of Clinical Oncology20 citations
Semantic Scholar
Sunitinib in combination with docetaxel and prednisone in patients (pts) with metastatic hormone-refractory prostate cancer (mHRPC).
A. Zurita, G. Liu, Thomas E. Hutson, M. Kozloff +6 more
2009Journal of Clinical Oncology18 citations
Semantic Scholar
Efficacy of gemcitabine and cisplatin (GP) as first-line combination therapy in patients with triple-negative metastatic breast cancer: Preliminary results report of a phase II trial.
Z. Wang, X. Hu, L. Chen, J. Wang +6 more
201012 citations
Semantic Scholar
166 A phase I dose-escalation study of anti-a5β1 integrin monoclonal antibody (M200) in patients with refractory solid tumors
A. Ricart, G. Liu, A. Tolcher, G. Schwartz +4 more
200412 citations
Semantic Scholar
Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet.
A. Armstrong, E. Antonarakis, M. Taplin, W. Kelly +28 more
2018Annals of Oncology11 citations Open access
Semantic Scholar
7047 POSTER A Phase I Pharmacodynamic Dose Escalation Study of Steroid Sulphatase Inhibitor Irosustat in Patients With Prostate Cancer
S. Denmeade, D. George, G. Liu, C. Peraire +4 more
20116 citations
Semantic Scholar
Clinical and dynamic imaging results of the first phase I study of AG-013736, an oral anti-angiogenesis agent, in patients (pts) with advanced solid tumors.
H. Rugo, R. Herbst, G. Liu, J. Park +6 more
2004Journal of Clinical Oncology6 citations
Semantic Scholar
Increased H1N1 Infection Rate in Asthmatic Children
K. Kloepfer, Jaime Olenec, Wai-Ming Lee, T. Pappas +5 more
20113 citations Open access
Semantic Scholar
1415P Phase II trial of a DNA vaccine with nivolumab in patients with PSA-recurrent, castration-sensitive prostate cancer (nmCSPC)
D. McNeel, H. Emamekhoo, J. Eickhoff, E. Wargowski +1 more
2022Annals of Oncology1 citations Open access
Semantic Scholar
A phase I study of R-(-)-gossypol (AT-101) in combination with cisplatin (P) and etoposide (E) in patients (pts) with advanced solid tumors and extensive-stage small cell lung cancer (ES-SCLC).
A. Traynor, J. Kolesar, R. Marnocha, J. Eikhoff +5 more
2011Journal of Clinical Oncology1 citations
Semantic Scholar
75P Comprehensive assessment of 18F-FDG PET/CT images of cancer patients improves predictions of survival
G. Liu, M. L. La Fontaine, A. Weisman, S. S. Houshmandi +3 more
2022Annals of Oncology0 citations Open access
Semantic Scholar
MO-AB-BRA-06: Dynamic FLT PET for Investigating Potential Synergistic Therapeutic Targets During Anti-Angiogenic Treatment.
M. Scarpelli, U. Simončič, S. Perlman, G. Liu +1 more
2016Medical Physics (Lancaster)0 citations
Semantic Scholar
TU-A-WAB-01: Characterization of Vascular and Proliferative Flare in Anti-Angiogenic Therapy Using FLT PET/CT and Circulating VEGF.
P. Scully, G. Liu, U. Simončič, R. Jeraj
2013Medical Physics (Lancaster)0 citations
Semantic Scholar
Phase I pharmacodynamic trial of sequential sunitinib (SU) with bevacizumab (bev) in patients with renal cell carcinoma (mRCC) and other advanced solid malignancies.
M. Harrison, R. Jeraj, H. Hammers, M. Stein +7 more
2011Journal of Clinical Oncology0 citations
Semantic Scholar
Effect of vaccination on immune and clinical responses in glioblastoma multiforme patients
C. Wheeler, K. Black, G. Liu, M. Mazer +6 more
20080 citations
Semantic Scholar
A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with docetaxel in patients with advanced solid tumors
F. Robert, A. Sandler, J. Schiller, J. Ilagan +7 more
20070 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

G. Wilding×4
Invite
G. Wilding — researcher profile on SciRah
R. Jeraj×4
Invite
R. Jeraj — researcher profile on SciRah
N. Shore×3
Invite
N. Shore — researcher profile on SciRah
G. Wilding×3
Invite
G. Wilding — researcher profile on SciRah

×3

Invite

D. George — researcher profile on SciRah

Invite

A. Zurita — researcher profile on SciRah

Thomas E. Hutson×2

Invite

Thomas E. Hutson — researcher profile on SciRah

Invite

M. Kozloff — researcher profile on SciRah

Invite

I. Chen — researcher profile on SciRah

C. Logothetis×2

Invite

C. Logothetis — researcher profile on SciRah

Invite

A. Traynor — researcher profile on SciRah

Invite

J. Kolesar — researcher profile on SciRah